The Ottawa Hospital — Ottawa, Ontario

Public research footprint of The Ottawa Hospital, compiled from the ClinicalTrials.gov public registry.

963

Registered studies

280

Active

164

Recruiting now

489

Completed

Stopped or withdrawn

Most-studied conditions

Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Advanced or Metastatic Non-small Cell Lung Cancer · Glioma · Thyroid Cancer

Recently updated registry entries

NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT05217446 — A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to… (Active Not Recruiting)
NCT04728893 — Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Ottawa Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.